Milestone Scientific (NYSE:MLSS) Earns Speculative Buy Rating from Analysts at Benchmark

Equities research analysts at Benchmark initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage set a “speculative buy” rating and a $1.25 price target on the stock. Benchmark’s target price would suggest a potential upside of 43.68% from the stock’s current price.

Separately, StockNews.com started coverage on shares of Milestone Scientific in a research report on Wednesday. They set a “hold” rating for the company.

Milestone Scientific Price Performance

NYSE MLSS opened at $0.87 on Thursday. Milestone Scientific has a twelve month low of $0.52 and a twelve month high of $1.10. The business has a 50-day moving average price of $0.96 and a 200-day moving average price of $0.80. The firm has a market cap of $67.19 million, a price-to-earnings ratio of -8.70 and a beta of 1.08.

Milestone Scientific (NYSE:MLSS) last posted its quarterly earnings results on Thursday, August 15th. The company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.01). Milestone Scientific had a negative return on equity of 60.78% and a negative net margin of 54.87%. The business had revenue of $1.85 million during the quarter.

Insider Buying and Selling

In other news, Director Leonard Osser sold 141,913 shares of the company’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $0.95, for a total transaction of $134,817.35. Following the sale, the director now directly owns 4,602,506 shares in the company, valued at approximately $4,372,380.70. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Over the last three months, insiders have sold 143,122 shares of company stock worth $136,026. Corporate insiders own 24.75% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.